Published in

Cancer Research, Statistics, and Treatment, 2(5), p. 395, 2022

DOI: 10.4103/crst.crst_137_22

Massachusetts Medical Society, New England Journal of Medicine, 7(386), p. 640-654, 2022

DOI: 10.1056/nejmoa2116133

Links

Tools

Export citation

Search in Google Scholar

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Journal article published in 2021 by Frederick L. Locke, Miguel-Angel Perales, Aaron P. Rapoport, Tom van Meerten ORCID, Patrick M. Reagan, Anna Sureda, Peter Vandenberghe, Kevin W. Song, Peter A. Riedell ORCID, Yin Yang, Jina Shah, Marco Schupp, Christina To, David B. Miklos, Jason R. Westin ORCID and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO